Design, synthesis and biological evaluation of 4-benzoyl-1-dichlorobenzoylthiosemicarbazides as potent Gram-positive antibacterial agents

References

• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1–12
   PubMed Web of Science ®Google Scholar
• Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155–64
   PubMed Web of Science ®Google Scholar
• Amin R, Krammer B, Abdel-Kader N, et al. Antibacterial effect of some benzopyrone derivatives. Eur J Med Chem 2010;45:372–8
   PubMed Web of Science ®Google Scholar
• Taubes G. The bacteria fight back. Science 2008;321:356–61
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Benjamin DK, et al. 10 × 20 Progress-development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 2013;56:1685–94
   PubMed Web of Science ®Google Scholar
• Hardej D, Ashby CR, Khadtare NS, et al. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains. Eur J Med Chem 2010;45:5827–32
   PubMed Web of Science ®Google Scholar
• LaDow JE, Warnock DC, Hamill KM, et al. Bicephalic amphiphile architecture affects antibacterial activity. Eur J Med Chem 2011;46:4219–26
   PubMed Web of Science ®Google Scholar
• Rice LB. Unmet medical needs in antibacterial therapy. Biochem Pharmacol 2006;71:991–5
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318–22
   PubMed Web of Science ®Google Scholar
• Siwek A, Stefańska J, Wawrzycka-Gorczyca I, Wujec M. Synthesis and in vitro antibacterial evaluation of 1-substituted-4-ethoxycarbonylmethylthiosemicarbazides and products of their dehydrocyclization. Heteroatom Chem 2010;21:131–8
   Web of Science ®Google Scholar
• Plech T, Wujec M, Siwek A, et al. Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety. Eur J Med Chem 2011;46:241–8
   PubMed Web of Science ®Google Scholar
• Siwek A, Stefańska J. Antimicrobial activity and SAR study of some novel thiosemicarbazide derivatives bearing piperidine moiety. Med Chem 2011;7:690–6
   PubMed Web of Science ®Google Scholar
• Siwek A, Stączek P, Wujec M, et al. Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides. J Mol Model 2011;17:2297–303
   PubMed Web of Science ®Google Scholar
• Siwek A, Stączek P, Stefańska J. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides. Eur J Med Chem 2011;46:5717–26
   PubMed Web of Science ®Google Scholar
• Siwek A, Stączek P, Kosikowska U, et al. Does dehydrocyclization of 4-benzoylthiosemicarbazides in acetic acid lead to s-triazoles or thiadiazoles? Struct Chem 2012;23:1441–8
   Web of Science ®Google Scholar
• CLSI, Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth International Supplement. CLSI Document M7-MIC. Wayne, PA: Clinical Laboratory Standards Institute; 2008
   Google Scholar
• Kaplan JB, Mulks MH. Biofilm formation is prevalent among field isolates of Actinobacillus pleuropneumoniae. Vet Microbiol 2005;108:89–94
   PubMed Web of Science ®Google Scholar
• Kosikowska U, Malm A. The preliminary analysis of the ability of biofilm formation in vitro under stationary conditions by Haemophilus parainfluenzae isolates from throat of healthy people. Sepsis 2009;2:203–6
   Google Scholar
• American National Standard. ANSI/AAMI/ISO 10993-5: 2009/(R)2014. Biological evaluation of medical devices, Part 5: Tests for in vitro cytotoxicity
   Google Scholar
• Hyperchem 8.0.3. HyperCube Inc., USA, Gainsville, FL, 2007
   Google Scholar
• Singh UCh, Kollman PA. An approach to computing electrostatic charges for molecules. J Comp Chem 1984;5:129–45
   Web of Science ®Google Scholar
• Frisch MJ. Gaussian 09, revision A.02. Wallingford: Gaussian Inc.; 2009
   Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) ECDC, Stockholm; 2010
   Google Scholar
• Henocq E, Hewitt B, Guerin B. Staphylococcal and human dander IgE antibodies in superinfected atopic dermatitis. Clin Allergy 1982;12:113–20
   PubMedGoogle Scholar
• Projan SJ, Novick RP. The molecular basis of pathogenicity. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone; 1997:55–82
   Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000;13:16–34
   PubMed Web of Science ®Google Scholar
• Foster TJ. Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion. Vet Dermatol 2009;20:456–70
   PubMed Web of Science ®Google Scholar
• Bronner S, Monteil H, Prevost G. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol Rev 2004;28:183–200
   PubMed Web of Science ®Google Scholar
• Cheung AL, Bayer AS, Zhang G, et al. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004;40:1–9
   PubMedGoogle Scholar
• Miller M, Dreisbach A, Otto A, et al. Mapping of interactions between human macrophages and Staphylococcus aureus reveals an involvement of map kinase signaling in the host defense. J Proteome Res 2011;10:4018–32
   PubMed Web of Science ®Google Scholar
• Jarvest RL, Berge JM, Berry V, et al. Nanomolar inhibitors of Staphylococcus aureus methionyl trna synthetase with potent antibacterial activity against Gram-positive pathogens. J Med Chem 2002;45:1959–62
   PubMed Web of Science ®Google Scholar
• Pillai A, Mitchell JL, Hill SL, Stockley RA. A case of Haemophilus parainfluenzae pneumonia. Thorax 2000;55:623–4
   PubMed Web of Science ®Google Scholar
• Frankard J, Rodriguez-Villalobos H, Struelens MJ, Jacobs F. Haemophilus parainfluenzae: an underdiagnosed pathogen of biliary tract infections? Eur J Clin Microbiol Infect Dis 2004;23:46–8
   PubMed Web of Science ®Google Scholar
• Cardines R, Giufre M, Atti ML, et al. Haemophilus parainfluenzae meningitis in an adult associated with acute otitis media. New Microbiol 2009;2:213–15
   Google Scholar
• Bjarnsholt T. The role of bacterial biofilms in chronic infections. Acta Pathol Mic Sc 2013;121:1–58
   Google Scholar
• Saginur R, StDenis M, Ferris W, et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006;50:55–61
   PubMed Web of Science ®Google Scholar